Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Melanoma 5Prostatic Neoplasms 3Neuroblastoma 3Neoplasm Metastasis 3Myelodysplastic Syndromes 3Multiple Myeloma 3Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Breast Neoplasms 3Brain Neoplasms 3Uveal Melanoma 2Pancreatic Neoplasms 2Osteosarcoma 2Oligodendroglioma 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Leukemia 2Glioma 2Ganglioneuroblastoma 2Carcinoma, Renal Cell 2Astrocytoma 2Sarcoma 1Rhabdoid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Plasma Cell 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1

Interventions

Granulocyte Colony-Stimulating Factor 7Filgrastim 7Etoposide 7Temozolomide 6Cyclophosphamide 6Carboplatin 6Vincristine 5Methotrexate 4Cisplatin 4tazemetostat 3etoposide phosphate 3Thiotepa 3Stem Cell Transplantation 3Peripheral Blood Stem Cell Transplantation 3Leucovorin 3ribociclib 2abemaciclib 2Vorinostat 2Sirolimus 2Radiotherapy 2Melphalan 2Irinotecan 2Busulfan 2veliparib 1trametinib 1sonidegib 1sargramostim 1reolysin 1pegylated granulocyte colony-stimulating factor 1palbociclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Rhabdoid Tumor × Colony-Stimulating Factors × Clear all
NCT02444546 2023-04-24

Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors

Mayo Clinic

Phase 1 Completed
6 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioma, Medulloblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡